Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.301% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] COc1ccc(Cn2c(C)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
[b] Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(Br)s2)cc1
Answer: b. Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(Br)s2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(Br)s2)cc1
Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(Br)s2)cc1
3-[(5-bromothiophen-2-yl)sulfonylamino]-N-[(4-methylphenyl)methyl]propanamide